Recent Updates
Recently added Catalysts
EVO Positive Sentiment Score: 75/100

Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management

Thursday, July 23, 2026 1 min read
Key Takeaway: Evotec has chosen Navan to oversee its corporate travel and expense management across key global markets. This collaboration aims to enhance operational efficiency by leveraging Navan's AI-driven platform. The decision reflects Evotec's commitment to modernizing its processes in the life sciences sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Evotec is modernizing its travel and expense management.
  • Navan's AI-powered platform will streamline processes.
  • The partnership enhances efficiency in top global markets.

Full Press Release Details

PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. A life science company that is pioneering the future of drug discovery and development, Evotec had historically managed T&E independentl

Frequently Asked Questions

What is the purpose of Evotec's partnership with Navan?

The partnership aims to manage Evotec's corporate travel and expense program.

How will Navan's platform benefit Evotec?

Navan's AI-powered platform will streamline Evotec's travel and expense processes.

In which markets will Evotec implement Navan's services?

Evotec will implement Navan's services in its top global markets.

What type of company is Evotec?

Evotec is a global drug discovery and development company.

Tags: EVO Viatris Investor Conferences Healthcare Evotec Navan travel management expense management AI-powered platform
Last updated: Jul 23, 2026

Biotech snapshot

Lead asset
EVT 302,Phase 2
Smoking Cessation →